糖尿病性骨质疏松症的中西医研究进展
Research Progress of Traditional Chinese Medicine and Western Medicine on Diabetes Osteoporosis
摘要: 伴随现代社会老龄化的加剧，糖尿病是目前世界上大多数人口的一类疾病，临床上发病率极高，并发症也众多，骨质疏松作为常见的并发症。本文则是对糖尿病性骨质疏松症(DPO)的中西医结合治疗的临床研究进行综述，中医有关于DOP的病因多认为脾虚、肾虚、血瘀，但研究不够扎实，对于一些疾病的机制解释不够深刻。西医对DOP的治疗多采取对症治疗，西药副作用较大且稳定性弱。而采用中西医结合治疗，可以提高该疾病治疗效果，也能克服西药的局限性，有良好的临床应用价值。该文总结相关文献，对相关研究进行综述。
Abstract: With the aggravation of aging in modern society, diabetes is a kind of disease of most people in the world at present. It has a very high incidence rate and many complications in clinic. Osteoporosis is a common complication. This article reviews the clinical research on the treatment of diabetes os-teoporosis (DPO) with integrated traditional Chinese and Western medicine. Traditional Chinese medicine believes that the etiology of DOP is spleen deficiency, kidney deficiency and blood stasis, but the research is not solid enough and the mechanism of some diseases is not profound enough. Western medicine mostly adopts Symptomatic treatment for DOP, which has large side effects and weak stability. The combination of traditional Chinese and Western medicine can improve the treatment effect of this disease and overcome the limitations of Western medicine, which has good clinical application value. This article summarizes relevant literature and provides a review of rel-evant research.
文章引用：丁思鹏, 吴静, 蔡达国, 喻佑齐, 彭松. 糖尿病性骨质疏松症的中西医研究进展[J]. 中医学, 2023, 12(8): 2114-2120. https://doi.org/10.12677/TCM.2023.128315

参考文献

[1] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中国实用内科杂志, 2018, 38(2): 127-150.
[2] Matzkin, E.G., De Maio, M., Charles, J.F. and Franklin, C.C. (2019) Diagnosis and Treatment of Oste-oporosis: What Orthopaedic Surgeons Need to Know. Journal of the American Academy of Orthopaedic Surgeons, 27, e902-e912. [Google Scholar] [CrossRef] 
[3] 郭玉卿, 王丽娜, 周慧敏. 抗氧化治疗老年糖尿病性骨质疏松的疗效[J]. 中国老年学杂志, 2015, 35(3): 671-672.
[4] Yamaguchi, T. and Sugimoto, T. (2012) Bone Metabolism and Fracture Risk in Type 2 Diabetes Mellitus. BoneKEy Reports, 1, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[5] Rathinavelu, S., Guidry-Elizondo, C. and Banu, J. (2018) Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes. Journal of Diabetes Research, 2018, Article ID: 6354787. [Google Scholar] [CrossRef] [PubMed]
[6] Keats, E.C., Dominguez, J.M., Grant, M.B. and Khan, Z.A. (2014) Switch from Canonical to Noncanonical Wnt Signaling Mediates High Glucose-Induced Adipogenesis. Stem Cells, 32, 1649-1660. [Google Scholar] [CrossRef] [PubMed]
[7] Alharbi, M.A., et al. (2018) FOXO1 Deletion Reverses the Ef-fect of Diabetic-Induced Impaired Fracture Healing. Diabetes, 67, 2682-2694. [Google Scholar] [CrossRef] [PubMed]
[8] Moradi, S., Shab-Bidar, S., Alizadeh, S. and Djafarian, K. (2017) Associa-tion between Sleep Duration and Osteoporosis Risk in Middle-Aged and Elderly Women: A Systematic Review and Me-ta-Analysis of Observational Studies. Metabolism, 69, 199-206. [Google Scholar] [CrossRef] [PubMed]
[9] 黄琪仁. 钙、维生素D与原发性骨质疏松症[J]. 中国实用妇科与产科杂志, 2014, 30(5): 336-340.
[10] 张鑫, 尹明贵. 2型糖尿病性骨质疏松患者血清TNF-α和BAP测定价值[J]. 河北医药, 2013, 35(19): 2936-2937.
[11] 王信, 张怡, 陈萍, 等. IL-6对RAW264.7细胞成熟分化的体外实验研究[J]. 中国骨质疏松杂志, 2019, 25(1): 62-66.
[12] Zhang, Q., Riddle, R.C. and Clemens, T.L. (2015) Bone and the Regulation of Global Energy Balance. Journal of Internal Medicine, 277, 681-689. [Google Scholar] [CrossRef] [PubMed]
[13] 陈贵平. 脂联素通过AMPK通路调节破骨细胞形成和骨吸收功能[D]: [硕士学位论文]. 南昌: 南昌大学, 2019.
[14] 黄帝内经素问[M]. 北京: 新世界出版社, 2015.
[15] 朱琦琦, 戴芳芳. 糖尿病性骨质疏松症的中医研究进展[J]. 中国骨质疏松杂志, 2019, 25(9): 1331-1335.
[16] 楚淑芳, 赵恒侠, 刘德亮, 等. 糖尿病性骨质疏松的中医药防治[J]. 世界中医药, 2018, 13(7): 1804-1808, 1812.
[17] 肖雪云, 陈汉礼, 许小志. 益肾活血方治疗糖尿病性骨质疏松症的临床研究[J]. 广州中医药大学学报, 2019, 36(7): 956-959.
[18] 张杰文, 谢政权, 林靖, 等. 季兵从肾虚血瘀论治糖尿病骨质疏松经验[J]. 湖南中医杂志, 2018, 34(5): 41-42.
[19] 黄菊, 舒仪琼. 温阳滋阴固肾法治疗糖尿病性骨质疏松症的研究进展[J]. 湖南中医杂志, 2015, 31(6): 176-178.
[20] 周建江, 卫四来. 中医药治疗原发性骨质疏松症研究进展[J]. 辽宁中医药大学学报, 2014, 16(7): 246-248.
[21] 应大文, 刘芳. 糖尿病与骨质疏松的相关性研究进展[J]. 实用预防医学, 2015, 22(10): 1275-1278.
[22] 李雪, 申意伟, 徐西林, 张晓峰, 吕航, 范桢亮, 彭宇飞, 张骋, 白洋. 补肾活血方治疗酒精性骨质疏松症临床疗效观察[J]. 辽宁中医药大学学报, 2019, 21(9): 196-199. [Google Scholar] [CrossRef] 
[23] 马如风, 郭鱼波, 王丽丽, 朱如愿, 左加成, 赵丹丹, 莫芳芳, 高思华, 张东伟. 糖尿病性骨质疏松的中医病因病机分析和临床研究进展[J]. 中华中医药学刊, 2016, 34(8): 1803-1806. [Google Scholar] [CrossRef] 
[24] 刘倩倩, 李春霖, 龚燕平. 老年男性骨质疏松症综合防治策略及指南解读[J]. 中国医药科学, 2021, 11(19): 23-28.
[25] 杨胜男. 糖尿病性骨质疏松症中西医治疗进展[J]. 亚太传统医药, 2018, 14(1): 87-89.
[26] Zhou, Z.E., Tang, Y., Jin, X., et al. (2016) Metformin Inhibits Ad-vanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activa-tion and RAGE/NF κ B Pathway Suppression. Journal of Diabetes Research, 2016, Article ID: 4847812. [Google Scholar] [CrossRef] [PubMed]
[27] Gu, Q., Gu, Y., Yang, H. and Shi, Q. (2017) Metformin Enhances Os-teogenesis and Suppresses Adipogenesis of Human Chorionic Villous Mesenchymal Stem Cells. The Tohoku Journal of Experimental Medicine, 241, 13-19. [Google Scholar] [CrossRef] [PubMed]
[28] Fronczek-Sokol, J. and Pytlik, M. (2014) Effect of Glimepiride on the Skeletal System of Ovariectomized and Non-Ovariectomized Rats. Pharmacological Reports, 66, 412-417. [Google Scholar] [CrossRef] [PubMed]
[29] 徐覃莎, 张海涛, 郁明姬, 等. 胰岛素及降糖药物治疗对2型糖尿病骨密度的影响[J]. 中国骨质疏松杂志, 2012, 18(10): 937-939.
[30] Schwartz, A.V., Sellmeyer, D.E., Ensrud, K.E., et al. (2001) Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study. The Journal of Clinical Endocrinology and Metabolism, 86, 32-38. [Google Scholar] [CrossRef] [PubMed]
[31] 江颖, 皮红英, 闫雅凤, 等. 老年男性骨质疏松症患者口服阿仑膦酸钠的依从性分析[J]. 中华内科杂志, 2013, 52(5): 387-389.
[32] Ho, Y.V., Frauman, A.G., Thomson, W., et al. (2000) Effects of Alendronate on Bone Density in Men with Primary and Secondary Osteoporosis. Osteoporosis Inter-national, 11, 98-101. [Google Scholar] [CrossRef] 
[33] Poole, K.E.S., Loveridge, N., Rose, C.M., et al. (2007) A Single Infusion of Zoledronate Prevents Bone Loss after Stroke. Stroke, 38, 1519-1525. [Google Scholar] [CrossRef] 
[34] 糖尿病合并骨质疏松中医诊疗标准[J]. 糖尿病天地(临床), 2016, 10(12): 554-559.
[35] 汪德芬. 吉海旺教授学术经验总结及辨治糖尿病性骨质疏松症临床研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2016.
[36] 戴丛书, 于卓, 李光耀, 林长青. 补肾壮骨汤治疗40例糖尿病性骨质疏松症的临床效果[J]. 世界最新医学信息文摘, 2019, 19(16): 160. [Google Scholar] [CrossRef] 
[37] 陈郭勋, 庞瑞明, 王明潮, 许长鹏. 身痛逐瘀汤治疗气滞血瘀型糖尿病性骨质疏松症疗效分析[J]. 河北中医, 2018, 40(11): 1652-1655+1686.
[38] 上官文姬, 李展春, 程光齐, 汤璐敏, 李鹤. 骨碎补总黄酮对绝经后骨质疏松大鼠疼痛介质和疼痛反应影响[J]. 辽宁中医药大学学报, 2017, 19(3): 10-12. [Google Scholar] [CrossRef] 
[39] 曹春雨, 刘婷, 回连强, 等. 黔岭淫羊藿总黄酮类成分对去势雌性大鼠骨质疏松症的实验研究[J]. 中国中药杂志, 2014, 39(10): 1913-1917.
[40] 陈克明. 淫羊藿总黄酮的抗骨质疏松作用机制[J]. 中华中医药杂志, 2017, 32(12): 5485-5489.
[41] Kang, S.N., Lee, J.S., Park, J.H., et al. (2015) In Vitro Anti-Osteoporosis Properties of Diverse Korean Drynariae Rhizoma Phenolic Extracts. Nutrients, 4, 1737-1751. [Google Scholar] [CrossRef] [PubMed]
[42] 李文, 顾春松, 管连城, 吴雍真, 李倩, 陈云志, 柴艺汇. 黄芪对D-半乳糖诱导骨髓间充质干细胞钙结节数、骨钙素mRNA及蛋白表达水平的影响[J]. 时珍国医国药, 2020, 31(11): 2586-2590.
[43] 张建平, 谢兴文, 李建国, 王兴盛, 武将, 景少博, 杨勇, 王博, 高学斌. 蛇床子提取物蛇床子素防治原发性骨质疏松症的研究概况[J]. 中国骨质疏松杂志, 2020, 26(10): 1546-1549.
[44] 邱世明, 王红伟. 针灸配合中药治疗骨质疏松症的临床观察[J]. 中国现代药物, 2020, 14(14): 211-213. [Google Scholar] [CrossRef] 
[45] 刘步云, 史梦龙, 刘灿坤. 中医推拿治疗骨质疏松症24例临床观察[J]. 新中医, 2017, 49(10): 82-84.